Similar articles for PMID: 22147380

Year	Number of Results
1949	1
1992	2
1999	1
2005	1
2006	1
2007	6
2008	7
2009	8
2010	9
2011	11
2012	10
2013	19
2014	16
2015	32
2016	27
2017	25
2018	24
2019	26
2020	44
2021	37
2022	31
2023	12
2024	0

1

Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.

Nguyen PL, Je Y, Schutz FA, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK. Nguyen PL, et al. JAMA. 2011 Dec 7;306(21):2359-66. doi: 10.1001/jama.2011.1745. JAMA. 2011. PMID: 22147380

2

Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis.

Bosco C, Bosnyak Z, Malmberg A, Adolfsson J, Keating NL, Van Hemelrijck M. Bosco C, et al. Eur Urol. 2015 Sep;68(3):386-96. doi: 10.1016/j.eururo.2014.11.039. Epub 2014 Dec 5. Eur Urol. 2015. PMID: 25484142 Free article. Review.

3

Is androgen deprivation therapy for prostate cancer associated with cardiovascular disease? A meta-analysis and systematic review.

Liang Z, Zhu J, Chen L, Xu Y, Yang Y, Hu R, Zhang W, Song Y, Lu Y, Ou N, Liu X. Liang Z, et al. Andrology. 2020 May;8(3):559-574. doi: 10.1111/andr.12731. Epub 2019 Dec 17. Andrology. 2020. PMID: 31743594 Free article.

4

A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients.

Jin C, Fan Y, Meng Y, Shen C, Wang Y, Hu S, Cui C, Xu T, Yu W, Jin J. Jin C, et al. Prostate Cancer Prostatic Dis. 2016 Dec;19(4):333-339. doi: 10.1038/pcan.2016.35. Epub 2016 Sep 6. Prostate Cancer Prostatic Dis. 2016. PMID: 27595915 Review.

5

Association of androgen deprivation therapy with thromboembolic events in patients with prostate cancer: a systematic review and meta-analysis.

Guo Z, Huang Y, Gong L, Gan S, Chan FL, Gu C, Xiang S, Wang S. Guo Z, et al. Prostate Cancer Prostatic Dis. 2018 Nov;21(4):451-460. doi: 10.1038/s41391-018-0059-4. Epub 2018 Jul 9. Prostate Cancer Prostatic Dis. 2018. PMID: 29988099

6

Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death.

Sanford NN, Chen MH, Loffredo M, Renshaw A, Kantoff PW, D'Amico AV. Sanford NN, et al. Prostate Cancer Prostatic Dis. 2017 Mar;20(1):79-84. doi: 10.1038/pcan.2016.53. Epub 2016 Nov 8. Prostate Cancer Prostatic Dis. 2017. PMID: 27824043 Free PMC article.

7

Cardiovascular events associated with androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis.

Carneiro A, Sasse AD, Wagner AA, Peixoto G, Kataguiri A, Neto AS, Bianco BA, Chang P, Pompeo AC, Tobias-Machado M. Carneiro A, et al. World J Urol. 2015 Sep;33(9):1281-9. doi: 10.1007/s00345-014-1439-6. Epub 2014 Nov 12. World J Urol. 2015. PMID: 25387877 Review.

8

Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis.

Botrel TE, Clark O, Lima Pompeo AC, Horta Bretas FF, Sadi MV, Ferreira U, Borges Dos Reis R. Botrel TE, et al. PLoS One. 2016 Jun 16;11(6):e0157660. doi: 10.1371/journal.pone.0157660. eCollection 2016. PLoS One. 2016. PMID: 27308831 Free PMC article. Review.

9

Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials.

Abufaraj M, Iwata T, Kimura S, Haddad A, Al-Ani H, Abusubaih L, Moschini M, Briganti A, Karakiewicz PI, Shariat SF. Abufaraj M, et al. Eur Urol. 2021 Jan;79(1):44-53. doi: 10.1016/j.eururo.2020.06.002. Epub 2020 Jun 27. Eur Urol. 2021. PMID: 32605859

10

Association of androgen deprivation therapy and depression in the treatment of prostate cancer: A systematic review and meta-analysis.

Nead KT, Sinha S, Yang DD, Nguyen PL. Nead KT, et al. Urol Oncol. 2017 Nov;35(11):664.e1-664.e9. doi: 10.1016/j.urolonc.2017.07.016. Epub 2017 Aug 10. Urol Oncol. 2017. PMID: 28803700 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

286 results

Results by year